Sfoglia per Autore
Immunovirological outcomes in 70 HIV-1-infected patients who switched to lopinavir/ritonavir after failing at least one protease inhibitor-containing regimen : a retrospective cohort study
2003 M. Bongiovanni, T. Bini, F. Tordato, P. Cicconi, S. Melzi, D. Repetto, S. Sollima, S. Rusconi, A. d'Arminio Monforte
Immunovirological outcomes in 70 HIV-1-infected patients who switched to lopinavir/ritonavir after failing at least one protease inhibitor-containing regimen: A retrospective cohort study
2003 M. Bongiovanni, T. Bini, F. Tordato, P. Cicconi, S. Melzi, D. Repetto, S. Sollima, S. Rusconi, A. d'Arminio Monforte
Simplification of protease inhibitor-containing regimens with efavirenz, nevirapine or abacavir : safety and efficacy outcomes
2003 E. Chiesa, T. Bini, F. Adorni, A. Capetti, G. Rizzardini, I. Faggion, C. Mussini, S. Sollima, S. Melzi, M. Bongiovanni, F. Tordato, P. Cicconi, B. Castelnuovo, S. Rusconi, A. D'Arminio Monforte
Pseudoaneurysm of the femoral artery in a HIV-infected man
2004 M. Bongiovanni, M. Pisacreta, M. Ortu, F. Tordato, R. Codemo, C. Gervasoni, R.Gornati, S. Trovati, R. Piolini, E. Chiesa, T. Porretta, T. Bini
Osteoporosis in HIV-infected subjects : a combined effect of highly active antiretroviral therapy and HIV itself?
2005 M. Bongiovanni, A. Fausto, P. Cicconi, L. Menicagli, S. Melzi, V.E. Ligabo, G. Cornalba, T. Bini, F. Sardanelli, A. D'Arminio Monforte
Zigomicosi polmonare in un soggetto immunocompetente
2006 M. Bongiovanni, E. Borghi, M. Falleni, R. Ranieri, M. Lafrancesca, A. D’Arminio Monforte, G. Morace
A comparison between abacavir and efavirenz as the third drug used in combination with a background therapy regimen of 2 nucleoside reverse-transcriptase inhibitors in patients with initially suppressed viral loads
2006 A. Cozzi-Lepri, A. De Luca, A.N. Phillips, M. Bongiovanni, S. Di Giambenedetto, M. Mena, M.C. Moioli, M. Arlotti, L. Sighinolfi, P. Narciso, M. Lichtner, R. Cauda, A. d’Arminio Monforte, ICoNA Study Group, UCSC-Roma HIV Cohort Study Group, IMIT Study Group
Highly active antiretroviral therapy reduces the age-associated risk of dementia in a cohort of older HIV-1-infected patients
2006 D. Larussa, P. Lorenzini, A. Cingolani, S. Bossolasco, S. Grisetti, M. Bongiovanni, F. Moretti, I. Uccella, P. Zannoni, S. Foresti, G. Mazzarello, M.I. Arcidiacono, R. Pedale, A. Ammassari, V. Tozzi, C.F. Perno, A. d’Arminio Monforte, P. Cinque, A. Antinori, Italian Registry Investigative Neuro AIDS (IRINA)
Lopinavir/ritonavir or efavirenz plus two nucleosides analogues as first-line antiretroviral therapy: a non-randomized comparison
2006 A. De Luca, A. Cozzi Lepri, A. Antinori, M. Zaccarelli, M. Bongiovanni, S. Di Giambenedetto, P. Marconi, P. Cicconi, F. Resta, B. Grisorio, M. Ciardi, A. d’Arminio Monforte, I.C.O.N.A. Ucsc, I. Mi, Inmi
Potential predictive factors of osteoporosis in HIV-positive subjects
2006 A. Fausto, M. Bongiovanni, P. Cicconi, L. Menicagli, E.V. Ligabò, S. Melzi, T. Bini, F. Sardanelli, G. Cornalba, A. d’Arminio Monforte
Bone diseases associated with human immunodeficiency virus infection: pathogenesis, risk factors and clinical management
2006 M. Bongiovanni, C. Tincati
Non-nucleoside-reverse-transcriptase-inhibitor-based HAART and osteoporosis in HIV-infected subjects
2006 M. Bongiovanni, A. Fausto, P. Cicconi, A. Aliprandi, G. Cornalba, T. Bini, F. Sardanelli, A. d'Arminio Monforte
Crohn's disease onset in an HIV/hepatitis C virus co-infected woman taking pegylated interferon α-2b plus ribavirin
2006 M. Bongiovanni, R. Ranieri, S. Ferrero, F. Casanova, A. D'Arminio Monforte
Long-term immunologic outcome in HAART-experienced subjects receiving lopinavir/ritonavir
2006 M. Bongiovanni, T. Bini, M. Casana, P. Cicconi, F. Tordato, A. d’Arminio Monforte
Subclinical hypothyroidism in HIV-infected subjects
2006 M. Bongiovanni, F. Adorni, M. Casana, F. Tordato, C. Tincati, P. Cicconi, T. Bini, A. d'Arminio Monforte
Prolonged survival of an HIV-infected subject with severe lymphoproliferative disease and rhinocerebral mucormycosis
2007 M. Bongiovanni, R. Ranieri, D. Ferrari, C. Codecà, T. Tartaro, L.D. Uziel
Is the CD4 cell percentage a better marker of immunosuppression than the absolute CD4 cell count in HIV-infected patients with cirrhosis?
2007 M. Bongiovanni, A. Gori, A. Cozzi-Lepri, A. Antinori, A. de Luca, G. Pagano, A. Chiodera, M. Puoti, A. d’Arminio Monforte, for the ICONA Cohort of Antiretroviral-Naive Patients Study Group
Observational study on HIV-infected subjects failing HAART receiving tenofovir plus didanosine as NRTI backbone
2007 M. Bongiovanni, N. Gianotti, E. Chiesa, P. Nasta, P. Cicconi, A. Capetti, A. di Biagio, A. Matti, V. Tirelli, P. Marconi, A. de Luca, C. Mussini, F. Gatti, M. Zaccarelli, C. Abeli, C. Torti, A. Antinori, A. Castagna, A. d’Arminio Monforte
Predictive factors of vascular intima media thickness in HIV-positive subjects
2008 M. Bongiovanni, M. Casana, P. Cicconi, M. Pisacreta, R. Codemo, M. Pelucchi, A. d’Arminio Monforte, T. Bini
Insulin resistance affects early virologic response in HIV-infected subjects treated for hepatitis C infection
2008 M. Bongiovanni, R. Ranieri, M. Casana, F. Tordato, P. Cicconi, C. Tincati, T. Bini, A. D'Arminio Monforte
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile